Skip to main content
Log in

A UK National Prescribing List?

  • Guest Editorial
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  1. House of Commons Health Committee. Priority setting in the NHS: the NHS drugs budget Vol.II: minutes or evidence and appendices London: Her Majesty’s Stationery OffICe. 1994 Jul

  2. House of Commons Health Committee. Priority setting in the NHS: the NHS drugs budget. Vol.I: report,tOgether with an appendix and the minutes of the committee. London: Her Majesty’s Stationery Office. 1994 Jul

  3. GPS against selected list, says ABPI. Scrip 1993 Jan 26; 1789: 2–3

    Google Scholar 

  4. Fellows P. A national formulary linked to a prescripction change policy. General Medical Services Committee discussion document. British Medical Association, 1995

    Google Scholar 

  5. Reilly A, Taylor R, Webster J. General practitioners’ attitudes towards the (1985) limited list. J R Coll Gen Pract 1986; 36: 151–2

    PubMed  CAS  Google Scholar 

  6. Field J. How do doctor and patients react to the introduction of a practice formulary? Fam Pract; 1989; 6: 135–40

    Article  PubMed  CAS  Google Scholar 

  7. Lumley P. A waste of taxpayers’ money? Scrip Mag 1994 Oct; 28: 26

    Google Scholar 

  8. UK MP opposition to national prescribing list. Scrip 1994 Jul 29; 1944: 4

    Google Scholar 

  9. Department of Health. Government response to the second report from the Health Committee, session 1993-4. London:Her Majesty’s Stationery Office, 1994 Oct

  10. Bate CM, Richardson P. Symptomatic assessment and cost effectiveness of treatmentsfor reflux oesophagitis:comparison of omeprazole and histamine H2 receptor antagonists. Br J Med Econ 1992; 37–48

    Google Scholar 

  11. Smith T. Limited lists of drugs; lessons from abroad. BMJ 1985; 290: 532–4

    Article  PubMed  CAS  Google Scholar 

  12. Pearce MJ, Begg E. A review of limited lists and formularies: are they cost–effective? Pharmacoeconomics 1992; 1: 191–202

    Article  PubMed  CAS  Google Scholar 

  13. Griffin T. The economic implications of therapeutic conservatism. Int Pharm J 1992: 6: 269–71

    Google Scholar 

  14. Garratini S, Garratini L. Pharmaceutical prescriptions in four European countries. Lancet 1993; 342: 191–2

    Article  Google Scholar 

  15. Push for UK national formulary. Scrip 1994 Jul 26; 1943: 2–4

    Google Scholar 

  16. Reilly P, Marinker M. Rational prescribing: can it be judged? In: Marinker M, editor. Controversies in health care policies. London: BMJ Publishing Group. 1994

    Google Scholar 

  17. Bligh J, Walley T. The UK indicative prescribing scheme. Parmacoeconomics 1992; 2: 137–152

    Article  CAS  Google Scholar 

  18. Glennerster H, Matsayines M, Owens P, et al. GP fundholding: wild card or winning hand? In: Robinson R, Le Grant J, editors. Evaluating the NHS reforms. London: King’s Fund Institute,1994: 74–107

    Google Scholar 

  19. Walley T, Wilson R, Bligh J. Current prescribing in primary care in the UK: effects of the indicative prescribing scheme and GP fundholding. Pharmacoeconomics 1995; 7 (4): 320–31

    Article  PubMed  CAS  Google Scholar 

  20. Harris C. Controlling the NHS drugs budget [letter]. BMJ 1994; 309: 738

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walley, T. A UK National Prescribing List?. Pharmacoeconomics 7, 471–474 (1995). https://doi.org/10.2165/00019053-199507060-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199507060-00001

Keywords

Navigation